A tüdőrák molekuláris diagnosztikája

Translated title of the contribution: Molecular diagnostics of lung cancer

A. Ryska, R. Dziadziuszko, W. Olszewski, P. Berzinec, B. Öz, M. Gottfried, T. Cufer, M. Samarzija, L. Plank, Gy Ostoros, J. Tímár

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Development of the target therapies of lung cancer was a rapid process which fundamentally changed the pathological diagnosis as well. Furthermore, molecular pathology became essential part of the routine diagnostics of lung cancer. These changes generated several practical problems and in underdeveloped countries or in those with reimbursement problems have been combined with further challenges. The central and eastern region of Europe are characterized by similar problems in this respect which promoted the foundation of NSCLC Working Group to provide up to date protocols or guidelines. This present paper is a summary of the molecular pathology and target therapy guidelines written with the notion that it has to be upgraded continuously according to the development of the field.

Original languageHungarian
Pages (from-to)259-266
Number of pages8
JournalMagyar Onkologia
Volume59
Issue number3
Publication statusPublished - Sep 1 2015

Fingerprint

Molecular Pathology
Lung Neoplasms
Guidelines
Eastern Europe
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ryska, A., Dziadziuszko, R., Olszewski, W., Berzinec, P., Öz, B., Gottfried, M., ... Tímár, J. (2015). A tüdőrák molekuláris diagnosztikája. Magyar Onkologia, 59(3), 259-266.

A tüdőrák molekuláris diagnosztikája. / Ryska, A.; Dziadziuszko, R.; Olszewski, W.; Berzinec, P.; Öz, B.; Gottfried, M.; Cufer, T.; Samarzija, M.; Plank, L.; Ostoros, Gy; Tímár, J.

In: Magyar Onkologia, Vol. 59, No. 3, 01.09.2015, p. 259-266.

Research output: Contribution to journalArticle

Ryska, A, Dziadziuszko, R, Olszewski, W, Berzinec, P, Öz, B, Gottfried, M, Cufer, T, Samarzija, M, Plank, L, Ostoros, G & Tímár, J 2015, 'A tüdőrák molekuláris diagnosztikája', Magyar Onkologia, vol. 59, no. 3, pp. 259-266.
Ryska A, Dziadziuszko R, Olszewski W, Berzinec P, Öz B, Gottfried M et al. A tüdőrák molekuláris diagnosztikája. Magyar Onkologia. 2015 Sep 1;59(3):259-266.
Ryska, A. ; Dziadziuszko, R. ; Olszewski, W. ; Berzinec, P. ; Öz, B. ; Gottfried, M. ; Cufer, T. ; Samarzija, M. ; Plank, L. ; Ostoros, Gy ; Tímár, J. / A tüdőrák molekuláris diagnosztikája. In: Magyar Onkologia. 2015 ; Vol. 59, No. 3. pp. 259-266.
@article{b257364d56934b2f9dee469ffe30718d,
title = "A t{\"u}dőr{\'a}k molekul{\'a}ris diagnosztik{\'a}ja",
abstract = "Development of the target therapies of lung cancer was a rapid process which fundamentally changed the pathological diagnosis as well. Furthermore, molecular pathology became essential part of the routine diagnostics of lung cancer. These changes generated several practical problems and in underdeveloped countries or in those with reimbursement problems have been combined with further challenges. The central and eastern region of Europe are characterized by similar problems in this respect which promoted the foundation of NSCLC Working Group to provide up to date protocols or guidelines. This present paper is a summary of the molecular pathology and target therapy guidelines written with the notion that it has to be upgraded continuously according to the development of the field.",
author = "A. Ryska and R. Dziadziuszko and W. Olszewski and P. Berzinec and B. {\"O}z and M. Gottfried and T. Cufer and M. Samarzija and L. Plank and Gy Ostoros and J. T{\'i}m{\'a}r",
year = "2015",
month = "9",
day = "1",
language = "Hungarian",
volume = "59",
pages = "259--266",
journal = "Magyar Onkologia",
issn = "0025-0244",
publisher = "Akademiai Kiado",
number = "3",

}

TY - JOUR

T1 - A tüdőrák molekuláris diagnosztikája

AU - Ryska, A.

AU - Dziadziuszko, R.

AU - Olszewski, W.

AU - Berzinec, P.

AU - Öz, B.

AU - Gottfried, M.

AU - Cufer, T.

AU - Samarzija, M.

AU - Plank, L.

AU - Ostoros, Gy

AU - Tímár, J.

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Development of the target therapies of lung cancer was a rapid process which fundamentally changed the pathological diagnosis as well. Furthermore, molecular pathology became essential part of the routine diagnostics of lung cancer. These changes generated several practical problems and in underdeveloped countries or in those with reimbursement problems have been combined with further challenges. The central and eastern region of Europe are characterized by similar problems in this respect which promoted the foundation of NSCLC Working Group to provide up to date protocols or guidelines. This present paper is a summary of the molecular pathology and target therapy guidelines written with the notion that it has to be upgraded continuously according to the development of the field.

AB - Development of the target therapies of lung cancer was a rapid process which fundamentally changed the pathological diagnosis as well. Furthermore, molecular pathology became essential part of the routine diagnostics of lung cancer. These changes generated several practical problems and in underdeveloped countries or in those with reimbursement problems have been combined with further challenges. The central and eastern region of Europe are characterized by similar problems in this respect which promoted the foundation of NSCLC Working Group to provide up to date protocols or guidelines. This present paper is a summary of the molecular pathology and target therapy guidelines written with the notion that it has to be upgraded continuously according to the development of the field.

UR - http://www.scopus.com/inward/record.url?scp=84952935571&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952935571&partnerID=8YFLogxK

M3 - Article

C2 - 26339915

AN - SCOPUS:84952935571

VL - 59

SP - 259

EP - 266

JO - Magyar Onkologia

JF - Magyar Onkologia

SN - 0025-0244

IS - 3

ER -